Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil

MLA

Jasper Ubels, et al. “Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-Effectiveness of RHD Screening in Brazil.” Global Heart, vol. 15, no. 1, Feb. 2020. EBSCOhost, https://doi.org/10.5334/gh.529.

APA

Jasper Ubels, Craig Sable, Andrea Z. Beaton, Maria Carmo P. Nunes, Kaciane K. B. Oliveira, Lara C. Castro, Isabella M. Teixeira, Gabriela Z. L. Ruiz, Letícia Maria M. Rabelo, Alison R. Tompsett, Antonio Luiz P. Ribeiro, Klas-Göran Sahlen, Bruno R. Nascimento, & On behalf of the PROVAR+ (Programa de RastreamentO da VAlvopatia Reumática e Outras Doenças Cardiovasculares) investigators. (2020). Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil. Global Heart, 15(1). https://doi.org/10.5334/gh.529

Chicago

Jasper Ubels, Craig Sable, Andrea Z. Beaton, Maria Carmo P. Nunes, Kaciane K. B. Oliveira, Lara C. Castro, Isabella M. Teixeira, et al. 2020. “Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-Effectiveness of RHD Screening in Brazil.” Global Heart 15 (1). doi:10.5334/gh.529.